Plenary Session 4: Hepatitis B: Pathways Forward
| Friday, August 14, 2026 |
| 9:00 AM - 11:00 AM |
Speaker
Dr Behzad Hajarizadeh
Associate Professor
UNSW/ Kirby Institute
HBsAg loss and functional cure among people with chronic hepatitis B in Australia within the REACH-B study
10:30 AM - 10:42 AMBiography
A/Professor Behzad Hajarizadeh is a clinical epidemiologist and an NHMRC Emerging Leadership Fellow in the Kirby Institute (UNSW). His main areas of research include epidemiology and clinical management of viral hepatitis, particularly in prison, and among people who inject drugs culturally and linguistically diverse communities.